Brief: Claritev Corp Q2 Revenue USD 257.478 Million Vs. IBES Estimate USD 244.8 Million
07/08/2026 10:01
BRIEF-Claritev Corp Q2 Revenue USD 257.478 Million Vs. IBES Estimate USD 244.8 Million Aug 07 (Reuters) - Claritev Corp Q2 operating income USD 23.409 million.
- Q2 pretax profit USD -76.649 million
- Q2 net income USD -59.226 million
- Q2 adjusted EBITDA USD 155.8 million vs. IBES estimate USD 147 million
- outlook FY revenue USD 1,000-1,020 million vs. IBES estimate USD 993.5 million
- outlook FY adjusted EBITDA USD 610-620 million vs. IBES estimate USD 608.5 million
- outlook FY capex USD 160-170 million
Recent news on Claritev
See all newsTPG explores $5 billion sale of healthcare software company Lyric, sources say
Brief: Marpai Expands Relationship With Claritev To Help Reduce Healthcare Costs For Employer Clients
Claritev Corp reports results for the quarter ended June 30 - Earnings Summary
Claritev Q2 revenue and adj EBITDA beat estimates, raises 2026 outlook
Brief: Claritev Corp Q2 Revenue USD 257.478 Million Vs. IBES Estimate USD 244.8 Million